Ha Jong-Hun, Shin Jeong-Ih, Kim Kyu-Min, Choi Jeong-Gyu, Trinh Minh Phuong, Anh Won Jun, Kang Kyung-Min, Kang Hyung-Lyun, Byun Jung-Hyun, Boonyanugomol Wongwarut, Kwon Kee Woong, Jung Myung Hwan, Baik Seung Chul, Lee Woo-Kon, Shin Min-Kyoung
Department of Microbiology, College of Medicine, Gyeongsang National University, Jinju, 52727, Republic of Korea.
Fastidious Specialized Pathogen Resources Bank, A Member of the National Culture Collection for Pathogens, Gyeongsang National University Hospital, Jinju, Republic of Korea.
Folia Microbiol (Praha). 2024 Oct 22. doi: 10.1007/s12223-024-01205-9.
Escherichia coli is a significant pathogen in extraintestinal infections, and ESBL-producing E. coli poses a major clinical challenge due to its antibiotic resistance. This study comprehensively analyzed E. coli isolates from urine and blood samples of patients with urinary tract and bloodstream infections at three major tertiary hospitals in South Korea. The goal was to provide insights into the distribution, antibiotic resistance, and virulence factors of these strains. Our analysis identified CTX-M and TEM as the dominant ESBL types, found in 71.7% and 61.7% of isolates, respectively, with 46.7% showing co-occurrence. Multilocus sequence typing (MLST) revealed the predominance of high-risk clones such as ST131, ST69, ST73, and ST95, with rare sequence types like ST410 and ST405 also identified. The high prevalence of virulence factors, including iutA (80.8%) and kpsMII (74.2%), further highlights the complexity of these strains. In addition, 38.3% of clinical isolates contained a combination of siderophore, adhesin, protectin, and toxin-related genes. There was no significant difference between urinary tract and bloodstream infections or regional differentiation in Korea. This study highlights the importance of controlling ESBL-producing E. coli infections, especially given the increasing incidence among patients with underlying medical conditions and older adults who are more susceptible to urinary tract infections. These findings serve as valuable indicators for pathogen analysis, especially those harboring antibiotic resistance and toxin genes. The insights gained are expected to contribute significantly to the development of infectious disease prevention and control strategies.
大肠埃希菌是引起肠外感染的重要病原菌,产超广谱β-内酰胺酶(ESBL)的大肠埃希菌因其抗生素耐药性而构成重大临床挑战。本研究全面分析了韩国三家大型三级医院尿路感染和血流感染患者尿液和血液样本中的大肠埃希菌分离株。目的是深入了解这些菌株的分布、抗生素耐药性和毒力因子。我们的分析确定CTX-M和TEM为主要的ESBL类型,分别在71.7%和61.7%的分离株中发现,46.7%的分离株同时出现这两种类型。多位点序列分型(MLST)显示高风险克隆如ST131、ST69、ST73和ST95占主导地位,同时也鉴定出了罕见的序列类型如ST410和ST405。毒力因子的高流行率,包括iutA(80.8%)和kpsMII(74.2%),进一步凸显了这些菌株的复杂性。此外,38.3%的临床分离株含有铁载体、黏附素、保护素和毒素相关基因的组合。韩国的尿路感染和血流感染之间或地区差异方面没有显著差异。本研究强调了控制产ESBL大肠埃希菌感染的重要性,特别是考虑到患有基础疾病的患者和更易患尿路感染的老年人中发病率不断上升的情况。这些发现是病原体分析的有价值指标,尤其是对于那些携带抗生素耐药性和毒素基因的病原体。预计所获得的见解将对传染病预防和控制策略的制定做出重大贡献。